Lopatin G - Search Results

1

Using a single parameter to describe time-activity curves.

Kwok CS, Frankel PH, Lopatin G, Williams LE. Kwok CS, et al. Among authors: lopatin g. Cancer Biother Radiopharm. 2014 Mar;29(2):83-6. doi: 10.1089/cbr.2013.1568. Epub 2014 Jan 2. Cancer Biother Radiopharm. 2014. PMID: 24383763 Free PMC article.

2

Review: update on selection of optimal radiopharmaceuticals for clinical trials.

Williams LE, Lopatin G, Kaplan DD, Liu A, Wong JY. Williams LE, et al. Among authors: lopatin g. Cancer Biother Radiopharm. 2008 Dec;23(6):797-806. doi: 10.1089/cbr.2008.0534. Cancer Biother Radiopharm. 2008. PMID: 19111048 Free PMC article. Review.

3

Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.

Williams LE, Liu A, Wu AM, Yazaki PJ, Yamauchi DM, Lopatin G, Raubitschek AA, Wong JY. Williams LE, et al. Among authors: lopatin g. Med Phys. 2000 May;27(5):988-94. doi: 10.1118/1.598963. Med Phys. 2000. PMID: 10841401

4

The two types of correction of absorbed dose estimates for internal emitters.

Williams LE, Liu A, Yamauchi DM, Lopatin G, Raubitschek AA, Wong JY. Williams LE, et al. Among authors: lopatin g. Cancer. 2002 Feb 15;94(4 Suppl):1231-4. doi: 10.1002/cncr.10290. Cancer. 2002. PMID: 11877750 Free article.

5

Exposure levels associated with Na(131)I thyroid cancer patients: correlation with initial activity and clinical physical parameters.

Pickering CA, Mas J, Dykes JN, Domingo MT, Yamauchi DM, Lopatin G, Williams LE. Pickering CA, et al. Among authors: lopatin g. Health Phys. 2014 Aug;107(2 Suppl 2):S163-5. doi: 10.1097/HP.0000000000000151. Health Phys. 2014. PMID: 24949923

6

Pharmacokinetic modeling and absorbed dose estimation for chimeric anti-CEA antibody in humans.

Odom-Maryon TL, Williams LE, Chai A, Lopatin G, Liu A, Wong YC, Chou J, Clarke KG, Raubitschek AA. Odom-Maryon TL, et al. Among authors: lopatin g. J Nucl Med. 1997 Dec;38(12):1959-66. J Nucl Med. 1997. PMID: 9430477 Free article. Clinical Trial.

7

Estimating residence times and their associated errors in patient absorbed-dose calculation.

Kaplan DD, Williams LE, Clarke KG, Odom-Maryon TL, Liu A, Lopatin G, Raubitschek AA, Wong JY. Kaplan DD, et al. Among authors: lopatin g. J Nucl Med Technol. 1997 Dec;25(4):264-8. J Nucl Med Technol. 1997. PMID: 9438927

8

Intrapatient consistency of imaging biodistributions and their application to predicting therapeutic doses in a phase I clinical study of 90Y-based radioimmunotherapy.

Clarke KG, Odom-Maryon TL, Williams LE, Liu A, Lopatin G, Chou J, Farino GM, Raubitschek AA, Wong JY. Clarke KG, et al. Among authors: lopatin g. Med Phys. 1999 May;26(5):799-809. doi: 10.1118/1.598588. Med Phys. 1999. PMID: 10360545 Clinical Trial.

9

A radionuclide therapy treatment planning and dose estimation system.

Liu A, Williams LE, Lopatin G, Yamauchi DM, Wong JY, Raubitschek AA. Liu A, et al. Among authors: lopatin g. J Nucl Med. 1999 Jul;40(7):1151-3. J Nucl Med. 1999. PMID: 10405136 Free article.

10

[Treatment of Botkin's disease in children].

LOPATIN GM. LOPATIN GM. Feldsher Akush. 1953 Jun;6:47-9. Feldsher Akush. 1953. PMID: 13083680 Undetermined Language. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters